Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

OBJECTIVE: There is a need for comparative studies to provide evidence-based treatment guidance for biologic agents in rheumatoid arthritis (RA). Therefore, this study was undertaken as the first head-to-head comparison of subcutaneous (SC) abatacept and SC adalimumab, both administered along with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinblatt, Michael E, Schiff, Michael, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Zhao, Cathy, Maldonado, Michael, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2013
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572583/
https://www.ncbi.nlm.nih.gov/pubmed/23169319
http://dx.doi.org/10.1002/art.37711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572583/
https://www.ncbi.nlm.nih.gov/pubmed/23169319
http://dx.doi.org/10.1002/art.37711

Ejemplares similares